Gilead
Gilead or Gilad is the ancient, historic, biblical name of the mountainous northern part of the region of Transjordan, present-day Jordan. The region is bounded in the west by the Jordan River, in the north by the deep ravine of the river Yarmouk and the region of Bashan, and in the southwest by what were known during antiquity as the "plains of Moab", with no definite boundary to the east. In some cases, "Gilead" is used in the Bible to refer to all the region east of the Jordan River. Gilead is situated in modern-day Jordan, corresponding roughly to the Irbid, Ajloun, Jerash and Balqa Governorates.
Recent news mentioning Gilead
- — Gilead Sciences Just Won Its Third FDA Approval in Less Than 4 Months. Is the Stock Still Underrating This Turnaround Play?
- — Gilead Keeps Writing Bigger Checks—But Can the Drugs Keep Paying for Them?
- — Is Gilead Sciences Stock Outperforming the S&P 500?
- — FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients
- — Gilead Sciences Has Snapped Out of Its Slump -- and 1 Catalyst Is Doing Most of the Heavy Lifting
- — Gilead’s Core Business Is Accelerating, But Will Its $11 Billion Pipeline Bet Pay Off?
- — Gilead’s HIV Business is Surging, but is the Company Too Dependent on One Franchise?
- — Gilead’s Revenue Is Accelerating, But are its Acquisitions Worth the Cost?
- — Pfizer vs. Gilead: Which Drugmaker Has the Stronger Growth Story?
- — Gilead Sciences Has Quietly Become One of the Most Underrated Turnaround Stories in Healthcare. Here's Why Wall Street Is Excited.
- — Gilead yanks out a thorn in its side in major court ruling
- — Can MacroGenics (MGNX) Turn Gilead Sciences (GILD)’s $10M Milestone Into a Major Pipeline Catalyst?